Literature DB >> 1709221

Protection against postischemic myocardial dysfunction in anesthetized rabbits with scavengers of oxygen-derived free radicals: superoxide dismutase plus catalase, N-2-mercaptopropionyl glycine and captopril.

J E Koerner1, B A Anderson, R C Dage.   

Abstract

Postischemic myocardial dysfunction in canine myocardium has been reported to be reduced by scavengers of oxygen-derived free radicals. One potential source of oxygen-derived free radicals in canine myocardium is xanthine oxidase, but human and rabbit myocardium either lack or possess very low levels of this enzyme. Therefore, the effects of scavengers of oxygen-derived free radicals on postischemic myocardial dysfunction produced by 15 min of ischemia and 3 h of reperfusion were evaluated in vivo in the rabbit. Superoxide dismutase (SOD) (45,000 U/kg) and catalase (55,000 U/kg) were given into the left atrium 10 min before ischemia, and followed by an additional 45,000 U/kg of SOD and 55,000 U/kg of catalase given over 85 min. This treatment reduced postischemic myocardial dysfunction, as did sulfhydryl-containing free radical scavengers N-2-mercaptopropionyl glycine (4 mg/kg, i.v.) and captopril (3 mg/kg, i.v.) given 5 min before and 60 min after reperfusion. SOD given alone at the same dose was ineffective, as was enalaprilat (0.3 mg/kg, i.v.), an angiotensin-converting enzyme inhibitor that does not scavenge oxygen-derived free radicals. Thus, postischemic myocardial dysfunction was reduced by scavengers of oxygen-derived free radicals in vivo in a species that is deficient in myocardial xanthine oxidase. This suggests that oxygen-derived free radicals derived from a source other than xanthine oxidase play a role in postischemic myocardial dysfunction.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1709221     DOI: 10.1097/00005344-199102000-00002

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  8 in total

1.  Comparison of the effects of different magnesium administration times on infarct size.

Authors:  Diego R Martínez Demaría; Horacio E Cingolani; Susana M Mosca
Journal:  Exp Clin Cardiol       Date:  2003

2.  Is the protection against ischemia induced by red wine linked to its antioxidant capacity?

Authors:  S M Mosca; G R Schinella; H A Tournier; H E Cingolani
Journal:  Exp Clin Cardiol       Date:  2001

3.  Enhanced expression of superoxide dismutase messenger RNA in viral myocarditis. An SH-dependent reduction of its expression and myocardial injury.

Authors:  H Suzuki; A Matsumori; Y Matoba; B S Kyu; A Tanaka; J Fujita; S Sasayama
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

Review 4.  Stunning: a radical re-view.

Authors:  D J Hearse
Journal:  Cardiovasc Drugs Ther       Date:  1991-10       Impact factor: 3.727

Review 5.  Captopril. A review of its pharmacology and therapeutic efficacy after myocardial infarction and in ischaemic heart disease.

Authors:  G L Plosker; D McTavish
Journal:  Drugs Aging       Date:  1995-09       Impact factor: 3.923

6.  Evidence for an essential role of reactive oxygen species in the genesis of late preconditioning against myocardial stunning in conscious pigs.

Authors:  J Z Sun; X L Tang; S W Park; Y Qiu; J F Turrens; R Bolli
Journal:  J Clin Invest       Date:  1996-01-15       Impact factor: 14.808

7.  Mitochondrial NHE1: a newly identified target to prevent heart disease.

Authors:  Bernardo V Alvarez; María C Villa-Abrille
Journal:  Front Physiol       Date:  2013-06-28       Impact factor: 4.566

8.  Molecular targets for anti-oxidative protection of green tea polyphenols against myocardial ischemic injury.

Authors:  Shih-Rong Hsieh; Wei-Chen Cheng; Yi-Min Su; Chun-Hwei Chiu; Ying-Ming Liou
Journal:  Biomedicine (Taipei)       Date:  2014-11-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.